Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1

NCT07122258 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC (Non-small Cell Lung Cancer)

Interventions

DEVICE: CAROL NSCLC treatment Device

Sponsor

Tau Medical Australia Pty Ltd

Collaborators

[object Object]